Savara Inc (SVRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.02B
Last updated: Nov 17, 2026 at 11:05 AM ET
Savara Inc (SVRA) Stock Forecast
Analysts expect Savara (SVRA) to earn -$0.64 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.23M. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 4 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 33.3% |
| Buy | 6 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 9
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 3596.0%.
- Fiscal year ending Dec 31, 2026
- -$0.64
- EPS consensus, revenue $2.23M
- Fiscal year ending Dec 31, 2027
- -$0.34
- EPS consensus, revenue $82.42M
- Next report
- Mar 11, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.64 | -$0.77 to -$0.59 | 6 | $2.23M | N/A | 7 |
| Dec 31, 2027 | -$0.34 | -$0.56 to -$0.06 | 5 | $82.42M | $64.40M to $153.00M | 8 |
Quarterly Estimates
The EPS consensus is -$0.16 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.16 | -$0.22 to -$0.12 | 11 | $1.84M | N/A | 11 |
| Mar 31, 2027 | -$0.16 | -$0.22 to -$0.12 | 4 | $7.37M | $3.00M to $18.00M | 6 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 8 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 4 |
| Fiscal year ending Dec 31, 2027 | 1 | 3 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.62.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.64 | -$0.65 | -$0.65 | -$0.62 | -$0.62 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.34 | -$0.37 | -$0.37 | -$0.31 | -$0.31 | N/A |
| Quarter ending Mar 31, 2027 | -$0.16 | -$0.16 | -$0.16 | -$0.13 | -$0.13 | N/A |
Frequently Asked Questions About SVRA
What is the SVRA stock forecast?
Consensus analyst estimates put Savara's EPS at -$0.64 for the fiscal year ending Dec 31, 2026, on revenue of $2.23M. The consensus rating from 9 analysts is Buy.
How do analysts rate SVRA stock?
Of 9 analysts covering Savara, 3 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SVRA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.64, with estimates from -$0.77 to -$0.59 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.34, with estimates from -$0.56 to -$0.06 from 5 analysts.
What revenue do analysts expect from Savara next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.23M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $82.42M, with estimates from $64.40M to $153.00M.
How many analysts cover SVRA?
9 analysts rate Savara stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SVRA pages: Overview, Earnings, Forecast, Financials, Competitors